Results 81 to 90 of about 44,755 (204)

Pharmacotherapy of von Willebrand disease

open access: yes, 2013
Introduction: Von Willebrand disease (VWD), the most common inherited bleeding disorder, is typically due to quantitative or qualitative deficiencies of von Willebrand factor (VWF).Areas covered: This review, which also summarizes the clinical ...
Franchini, Massimo, Lippi, Giuseppe
core   +1 more source

Aortic Stenosis and Acquired von Willebrand Disease: Lack of Association

open access: yes, 2011
Objectives: The association between aortic stenosis (AS) and acquired von Willebrand disease type 2A has been described. It may be present in up to 90% of patients with AS.
Zalaquett, Ricardo   +17 more
core   +1 more source

Recent advances in the diagnosis of von Willebrand disease

open access: yesLabMed Discovery
Von Willebrand disease (VWD) is caused by a quantitative or qualitative defect of von Willebrand factor (VWF). Despite its prevalence as the most common hereditary bleeding disorder and the associated morbidity, its diagnosis and classification remains a
Qian Liang, Renhao Li
doaj   +1 more source

Exposure–Response Relationship between VWF/FVIII Activity and Spontaneous Bleeding Events Following Recombinant VWF Prophylaxis in Severe VWD

open access: yesTH Open
Background Recombinant von Willebrand factor (rVWF, vonicog alfa, Takeda Pharmaceuticals USA) is indicated in adults diagnosed with von Willebrand disease (VWD).
Frank W.G. Leebeek   +7 more
doaj   +1 more source

Decreased plasma ADAMTS-13 activity as a predictor of postoperative bleeding in cyanotic congenital heart disease

open access: yesClinics, 2013
OBJECTIVE: To analyze the preoperative plasma antigenic concentration and activity of von Willebrand factor and its main cleaving protease ADAMTS-13 in pediatric patients with cyanotic congenital heart disease undergoing surgical treatment and ...
Rosangela P.S. Soares   +4 more
doaj  

Bioequivalence of von Willebrand factor-containing concentrates: implications for the choice in patients with von Willebrand disease. A position paper from the Italian Association of Hemophilia Centers

open access: yesBleeding, Thrombosis and Vascular Biology
Von Willebrand disease (VWD) is a bleeding disorder caused by quantitative and/or qualitative defects of von Willebrand factor (VWF), a multimeric glycoprotein synthesized by endothelial cells and megakaryocytes. VWF plays a crucial role in hemostasis by
Ezio Zanon   +7 more
doaj   +1 more source

The elusive and heterogeneous pattern of type 2M von Willebrand disease: A diagnostic challenge

open access: yes, 2018
Type 2M is a very heterogeneous form of von Willebrand disease (VWD) associated with impaired platelet and von Willebrand factor (VWF) interactions not due to a lack of large VWF ...
Casonato, Alessandra   +5 more
core   +1 more source

Unexpected massive bleeding during the modified LeFort III advancement surgery for Crouzon syndrome: A case report

open access: yesClinical Case Reports
Key Clinical Message Vigilant monitoring for postoperative complications, including bleeding and dysrhythmia, is crucial in patients with craniosynostosis syndromes like Crouzon syndrome undergoing craniofacial surgery, with a thorough evaluation ...
Zahra Sadat Modarresi   +3 more
doaj   +1 more source

Intravenous Immunoglobulin offers temporary improvement in acquired von Willebrand syndrome due to monoclonal gammopathy: A case report

open access: yeseJHaem
Acquired von Willebrand syndrome (AVWS) is a bleeding disorder in which an underlying condition induces a quantitative or qualitative deficiency in the von Willebrand factor.
Kevin G. Zablonski   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy